tiprankstipranks
Trending News
More News >
Lineage Cell announces 36-month results for Phase 1/2a trial of RG6501
PremiumThe FlyLineage Cell announces 36-month results for Phase 1/2a trial of RG6501
28d ago
Is LCTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is LCTX a Buy, Before Earnings?
29d ago
Lineage Cell Therapeutics price target lowered to $3 from $4 at B. Riley
Premium
The Fly
Lineage Cell Therapeutics price target lowered to $3 from $4 at B. Riley
3M ago
Options Volatility and Implied Earnings Moves Today, March 10, 2025
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, March 10, 2025
3M ago
Options Volatility and Implied Earnings Moves This Week, March 10 – March 14, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, March 10 – March 14, 2025
3M ago
Lineage Cell Therapeutics, Inc. (LCTX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Lineage Cell Therapeutics, Inc. (LCTX) Q4 Earnings Cheat Sheet
3M ago
Lineage Cell Therapeutics price target lowered to $3 from $5 at Maxim
PremiumThe FlyLineage Cell Therapeutics price target lowered to $3 from $5 at Maxim
5M ago
Lineage Cell price target lowered to $2 from $3 at D. Boral Capital
Premium
The Fly
Lineage Cell price target lowered to $2 from $3 at D. Boral Capital
5M ago
Lineage Cell Therapeutics price target raised to $9 from $7 at H.C. Wainwright
Premium
The Fly
Lineage Cell Therapeutics price target raised to $9 from $7 at H.C. Wainwright
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100